Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 12)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Reuters Investment Profile N/A Andes Energia Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Antrim Energy Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Adeona Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Antrim Energy Inc. 42 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
15-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
4-Jan-10 Global Markets Direct Global Markets Direct Antrim Energy Inc. Financial and Strategic Analysis Review 56 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
Next 2

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Mar-09 CIBC World Markets Mark Bridges CFA, Robert Pare CFA, Brad Borggard CFA, William S. Lee P. Eng, Christine Ezinga, Adam Gill, Vladislav Vlad, John Prins CA The Oil & Gas Trust/Junior Weekly 21 $90 View Abstract

Independent Reports (Showing 1 to 10 of 11)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Reuters Investment Profile N/A Andes Energia Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Antrim Energy Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Adeona Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Antrim Energy Inc. 42 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
15-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADEONA PHARMACEUTICALS INC 5 $25 View Abstract
4-Jan-10 Global Markets Direct Global Markets Direct Antrim Energy Inc. Financial and Strategic Analysis Review 56 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
Next 1

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.